A novel approach to safer glucocorticoid receptor–targeted anti-lymphoma therapy via REDD1 (regulated in development and DNA damage 1) inhibition
Ekaterina A. Lesovaya, Alena V. Savinkova, Olga V. Morozova, Evgeniya S. Lylova, Ekaterina M. Zhidkova, Evgeny P. Kulikov, Kirill I. Kirsanov, Anna Klopot, Gleb Baida, Marianna G. Yakubovskaya, Leo I. Gordon, Ben Readhead, Joel T. Dudley, Irina Budunova
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A novel approach to safer glucocorticoid receptor–targeted anti-lymphoma therapy via REDD1 (regulated in development and DNA damage 1) inhibition'. Together they form a unique fingerprint.